- Home
- Publications
- Publication Search
- Publication Details
Title
NAMPT: A critical driver and therapeutic target for cancer
Authors
Keywords
NAMPT, NAD, Metabolism, Cancer biology, Tumor microenvironment, Immune cell regulation, Cancer therapy
Journal
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Volume 145, Issue -, Pages 106189
Publisher
Elsevier BV
Online
2022-02-25
DOI
10.1016/j.biocel.2022.106189
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- eNAMPT is a Novel DAMP that Contributes to the Severity of Radiation-Induced Lung Fibrosis
- (2022) Alexander N. Garcia et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Macrophages provide a transient muscle stem cell niche via NAMPT secretion
- (2021) Dhanushika Ratnayake et al. NATURE
- Enzymology of extracellular NAD metabolism
- (2021) Massimiliano Gasparrini et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A Stat1 bound enhancer promotes Nampt expression and function within tumor associated macrophages
- (2021) Thomas B. Huffaker et al. Nature Communications
- Advances in NAD-Lowering Agents for Cancer Treatment
- (2021) Moustafa S. Ghanem et al. Nutrients
- The balance between NAD+ biosynthesis and consumption in ageing
- (2021) Øyvind Strømland et al. MECHANISMS OF AGEING AND DEVELOPMENT
- The Extracellular NADome Modulates Immune Responses
- (2021) Valentina Audrito et al. Frontiers in Immunology
- A nicotinamide phosphoribosyltransferase–GAPDH interaction sustains the stress-induced NMN/NAD+ salvage pathway in the nucleus
- (2020) Ambra A Grolla et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5)
- (2020) Simone Torretta et al. Cells
- Beyond Energy Metabolism: Exploiting the Additional Roles of NAMPT for Cancer Therapy
- (2020) Christine M. Heske Frontiers in Oncology
- Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis
- (2020) Giorgia Colombo et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome
- (2020) Tania Romacho et al. Scientific Reports
- Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy
- (2020) Ubaldina Galli et al. Frontiers in Pharmacology
- NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation
- (2020) Valentina Audrito et al. Frontiers in Oncology
- A decrease in NAMPT activity impairs basal PARP-1 activity in cytidine deaminase deficient-cells, independently of NAD+
- (2020) Sandra Cunha Silveira et al. Scientific Reports
- NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma
- (2020) Valentina Audrito et al. Cancers
- Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells
- (2019) Cristina Travelli et al. CANCER RESEARCH
- Nuclear transport of nicotinamide phosphoribosyltransferase is cell cycle dependent in mammalian cells and its inhibition slows cell growth
- (2019) Petr Svoboda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NAMPT regulates PKM2 nuclear location through 14‐3‐3ζ: Conferring resistance to tamoxifen in breast cancer
- (2019) Xin Ge et al. JOURNAL OF CELLULAR PHYSIOLOGY
- NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling
- (2019) Sudhir Chowdhry et al. NATURE
- Subcellular compartmentalization of NAD+ and its role in cancer: A sereNADe of metabolic melodies
- (2019) Yi Zhu et al. PHARMACOLOGY & THERAPEUTICS
- NAMPT as a Dedifferentiation-Inducer Gene: NAD+ as Core Axis for Glioma Cancer Stem-Like Cells Maintenance
- (2019) Antonio Lucena-Cacace et al. Frontiers in Oncology
- Extracellular Vesicle-Contained eNAMPT Delays Aging and Extends Lifespan in Mice
- (2019) Mitsukuni Yoshida et al. Cell Metabolism
- NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer
- (2019) Valentina Audrito et al. Frontiers in Immunology
- Oncogenic USP22 supports gastric cancer growth and metastasis by activating c-Myc/NAMPT/SIRT1-dependent FOXO1 and YAP signaling
- (2019) Hongxia Liu et al. Aging-US
- Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin
- (2019) Zahra Bolandghamat Pour et al. BMC CANCER
- Extracellular nicotinate phosphoribosyltransferase binds Toll like receptor 4 and mediates inflammation
- (2019) Antonella Managò et al. Nature Communications
- Novel Mechanism for Nicotinamide Phosphoribosyltransferase Inhibition of TNF-α–mediated Apoptosis in Human Lung Endothelial Cells
- (2018) Radu C. Oita et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade
- (2018) Mehdi Touat et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of NAMPT sensitizes MOLT4 leukemia cells for etoposide treatment through the SIRT2-p53 pathway
- (2018) Theresa Grohmann et al. LEUKEMIA RESEARCH
- The role of extracellular and intracellular Nicotinamide phosphoribosyl-transferase in cancer: Diagnostic and therapeutic perspectives and challenges
- (2018) Maria Dalamaga et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- NAMPT: a pleiotropic modulator of monocytes and macrophages
- (2018) Cristina Travelli et al. PHARMACOLOGICAL RESEARCH
- NAMPT signaling is critical for the proangiogenic activity of tumor-associated neutrophils
- (2018) Ekaterina Pylaeva et al. INTERNATIONAL JOURNAL OF CANCER
- Increased Nicotinamide adenine dinucleotide pool promotes colon cancer progression by suppressing reactive oxygen species level
- (2018) Sun M. Hong et al. CANCER SCIENCE
- SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells
- (2018) Giovanna Sociali et al. FASEB JOURNAL
- The c-MYC/NAMPT/SIRT1 feedback loop is activated in early classical and serrated route colorectal cancer and represents a therapeutic target
- (2018) Lydia Brandl et al. MEDICAL ONCOLOGY
- NAD Metabolism in Cancer Therapeutics
- (2018) Keisuke Yaku et al. Frontiers in Oncology
- PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes
- (2017) Rebecca Gupte et al. GENES & DEVELOPMENT
- Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma
- (2017) Valentina Audrito et al. JNCI-Journal of the National Cancer Institute
- NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis
- (2017) Antonio Lucena-Cacace et al. Oncotarget
- Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma
- (2017) Valentina Audrito et al. JNCI-Journal of the National Cancer Institute
- Extracellular nicotinamide phosphoribosyltransferase, a new cancermetabokine
- (2016) Ambra A Grolla et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- NAD+ salvage pathway in cancer metabolism and therapy
- (2016) Barry E. Kennedy et al. PHARMACOLOGICAL RESEARCH
- An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma
- (2016) Amit D. Gujar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of NAD biosynthetic enzymes modulates NAD-sensing processes to shape mammalian cell physiology under varying biological cues
- (2015) Silverio Ruggieri et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion
- (2015) Kensuke Tateishi et al. CANCER CELL
- SIRT1-Mediated eNAMPT Secretion from Adipose Tissue Regulates Hypothalamic NAD+ and Function in Mice
- (2015) Myeong Jin Yoon et al. Cell Metabolism
- NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus
- (2015) Carles Cantó et al. Cell Metabolism
- Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells
- (2015) Bo Tan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Physiological and pathophysiological roles of NAMPT and NAD metabolism
- (2015) Antje Garten et al. Nature Reviews Endocrinology
- Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer
- (2015) Deepak Sampath et al. PHARMACOLOGY & THERAPEUTICS
- NAD Biosynthesis in Humans - Enzymes, Metabolites and Therapeutic Aspects
- (2015) Christian Dölle et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Unique Toll-Like Receptor 4 Activation by NAMPT/PBEF Induces NFκB Signaling and Inflammatory Lung Injury
- (2015) Sara M. Camp et al. Scientific Reports
- Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia
- (2014) Valentina Audrito et al. BLOOD
- Synergy between the NAMPT Inhibitor GMX1777(8) and Pemetrexed in Non-Small Cell Lung Cancer Cells Is Mediated by PARP Activation and Enhanced NAD Consumption
- (2014) M. Chan et al. CANCER RESEARCH
- Novel assay for simultaneous measurement of pyridine mononucleotides synthesizing activities allows dissection of the NAD+biosynthetic machinery in mammalian cells
- (2014) Federica Zamporlini et al. FEBS Journal
- Nicotinamide Phosphoribosyltransferase Promotes Epithelial-to-Mesenchymal Transition as a Soluble Factor Independent of Its Enzymatic Activity
- (2014) Debora Soncini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metabolomics Analysis of Metabolic Effects of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibition on Human Cancer Cells
- (2014) Vladimir Tolstikov et al. PLoS One
- NAD+ and sirtuins in aging and disease
- (2014) Shin-ichiro Imai et al. TRENDS IN CELL BIOLOGY
- Intracellular NAD+ depletion enhances bortezomib-induced anti-myeloma activity
- (2013) A. Cagnetta et al. BLOOD
- The importance of NAMPT/NAD/SIRT1 in the systemic regulation of metabolism and ageing
- (2013) S. Imai et al. DIABETES OBESITY & METABOLISM
- Nampt secreted from cardiomyocytes promotes development of cardiac hypertrophy and adverse ventricular remodeling
- (2012) Vinodkumar B. Pillai et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Nampt/Visfatin/PBEF: A Functionally Multi-faceted Protein with a Pivotal Role in Malignant Tumors
- (2012) He Jieyu et al. CURRENT PHARMACEUTICAL DESIGN
- Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells
- (2012) Ilirjana Bajrami et al. EMBO Molecular Medicine
- Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+Biosynthesis, in Human Cancer Cells
- (2012) Bo Tan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NAD+-dependent Sirtuin 1 and 6 Proteins Coordinate a Switch from Glucose to Fatty Acid Oxidation during the Acute Inflammatory Response
- (2012) Tie Fu Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Monocytes Contribute to Differential Immune Pressure on R5 versus X4 HIV through the Adipocytokine Visfatin/NAMPT
- (2012) Rafael Van den Bergh et al. PLoS One
- Nampt is involved in DNA double-strand break repair
- (2012) Bingtao Zhu et al. Chinese Journal of Cancer
- Characterization of human nicotinate phosphoribosyltransferase: Kinetic studies, structure prediction and functional analysis by site-directed mutagenesis
- (2011) Lucia Galassi et al. BIOCHIMIE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans
- (2011) D. Friebe et al. DIABETOLOGIA
- Inhibition of nicotinamide phosphoribosyltransferase modifies LPS-induced inflammatory responses of human monocytes
- (2011) Erik Schilling et al. Innate Immunity
- Nicotinamide Phosphoribosyltransferase/Visfatin Does Not Catalyze Nicotinamide Mononucleotide Formation in Blood Plasma
- (2011) Nobumasa Hara et al. PLoS One
- The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop
- (2011) A. Menssen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Secret Life of NAD+: An Old Metabolite Controlling New Metabolic Signaling Pathways
- (2010) Riekelt H. Houtkooper et al. ENDOCRINE REVIEWS
- Inhibition of Nicotinamide Phosphoribosyltransferase
- (2010) Maria Pittelli et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response
- (2010) B Wang et al. ONCOGENE
- Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes
- (2009) A. Garten et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Visfatin through STAT3 activation enhances IL-6 expression that promotes endothelial angiogenesis
- (2009) Jee-Young Kim et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The Nicotinamide Phosphoribosyltransferase: A Molecular Link between Metabolism, Inflammation, and Cancer
- (2009) M. Galli et al. CANCER RESEARCH
- NAMPT is essential for the G-CSF–induced myeloid differentiation via a NAD+–sirtuin-1–dependent pathway
- (2009) Julia Skokowa et al. NATURE MEDICINE
- Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-κB activation in endothelial cells
- (2008) Su-Ryun Kim et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now